When Does the Cardiovascular Disease Appear in Patients With Chronic Kidney Disease?

被引:10
|
作者
Sozeri, Betul [1 ]
Mir, Sevgi [1 ]
Kara, Orhan Deniz [1 ]
Levent, Erturk [2 ]
机构
[1] Ege Univ, Fac Med, Dept Pediat Nephrol, Izmir, Turkey
[2] Ege Univ, Fac Med, Dept Pediat Cardiol, Izmir, Turkey
关键词
Cardiovascular disease; Children; Chronic kidney disease; LEFT-VENTRICULAR MASS; STAGE RENAL-DISEASE; ALL-CAUSE MORTALITY; ARTERIAL STIFFNESS; PEDIATRIC-PATIENTS; AORTIC STIFFNESS; ABDOMINAL-AORTA; YOUNG-ADULTS; CHILDREN; RISK;
D O I
10.1007/s00246-010-9710-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease is a leading cause of long-term morbidity and mortality among children with chronic kidney disease (CKD). At which stage of CKD these appear in children is unknown. This study aimed to determine the prevalence of cardiovascular disease in pediatric CKD patients and to explore the relationship of these changes and treatment methods. The study enrolled pediatric patients with stages 1-5 CKD including 20 patients receiving predialysis (PreD), 8 receiving peritoneal dialysis, and 14 receiving hemodialysis. Aortic stiffness, defined as decreased aortic strain (S) and increased pressure strain normalized by diastolic pressure (Ep*), was described. Sonography of the common carotid artery and left ventricle was performed. The mean age of the children was 13.3 +/- A 5.3 years. The patients had lower S values (0.35 +/- A 0.23) than the control subjects (0.44 +/- A 0.2) (P < 0.05) but higher Ep* (2.46 +/- A 1.31 vs. 1.32 +/- A 0.09; P < 0.05). Aortic stiffness was found in 13 patients. The PreD group had lower As levels than the dialysis group but higher levels than the control group. The patients (n = 32) had greater carotid intima-media thickness than the control subjects (0.58 +/- A 0.14 vs. 0.35 +/- A 0.12; P < 0.05). The intima-media thickness was greatest in the PreD group (P < 0.05). The patients had a higher left ventricular mass index (LVMI; 42.4 +/- A 15.6) than the control subjects (28.8 +/- A 8.47) (P < 0.05) and a larger left ventricle end diastolic diameter (LVEDD; 3.44 +/- A 0.76 vs. 2.59 +/- A 0.34; P < 0.05). Left ventricular hypertrophy was found in 32 patients. Both LVMI and LVEDD were higher in the groups receiving hemodialysis and lower in the PreD group. Increased carotid-intima media thickness and left ventricle hypertrophy appeared without hypertension in the PreD group. The indications and timing of dialysis should be reevaluated for children with CKD. In the dialysis groups, fewer cardiovascular changes were found with peritoneal dialysis than with hemodialysis. Therefore, peritoneal dialysis should be preferable to hemodialysis for children with CKD.
引用
收藏
页码:821 / 828
页数:8
相关论文
共 50 条
  • [31] Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter
    Levin, A
    Djurdjev, O
    Barrett, B
    Burgess, E
    Carlisle, E
    Ethier, J
    Jindal, K
    Mendelssohn, D
    Tobe, S
    Singer, J
    Thompson, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) : 1398 - 1407
  • [32] In response to the article "The challenge of cardiovascular disease in patients with chronic kidney disease"
    Barrionuevo, Juan de Dios Arjona
    Sacaluga, Luis Gil
    Vargas-Machuca, Manuel Gonzales
    Marquez, Francisco Guerrero
    Hidalgo, Ignacio Sainz
    Mendoza, Manuel Lopez
    Govantes, Gentil
    NEFROLOGIA, 2023, 43 (04): : 511 - 512
  • [33] SKIN AUTOFLUORESCENCE IS A PREDICTOR OF CARDIOVASCULAR DISEASE IN CHRONIC KIDNEY DISEASE PATIENTS
    Nara, Kimie
    Furuya, Fumihiko
    Haraguchi, Kazutaka
    Kitamura, Kenichiro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [34] IS CHRONIC KIDNEY DISEASE A RISK FACTOR FOR CARDIOVASCULAR DISEASE IN ELDERLY PATIENTS?
    Pacurari, A.
    Serban, C.
    Narita, A.
    Romosan, I.
    JOURNAL OF HYPERTENSION, 2010, 28 : E512 - E512
  • [35] Skin Autofluorescence Is a Predictor of Cardiovascular Disease in Chronic Kidney Disease Patients
    Furuya, Fumihiko
    Shimura, Hiroki
    Takahashi, Kazuya
    Akiyama, Daiichiro
    Motosugi, Ai
    Ikegishi, Yukinobu
    Haraguchi, Kazutaka
    Kobayashi, Tetsuro
    THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (01) : 40 - 44
  • [36] Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease
    Jessica Kendrick
    Michel B Chonchol
    Nature Clinical Practice Nephrology, 2008, 4 : 672 - 681
  • [37] Cardiovascular disease in patients with stage IV and V of chronic kidney disease
    Castellanos Heredia, Jose E.
    Morales Jimenez, Edelsy
    Mayo Salazar, Alexis
    Paez Quevedo, Saili
    INSUFICIENCIA CARDIACA, 2014, 9 (03) : 105 - 111
  • [38] Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease
    Sehrish Ali
    Natasha Dave
    Salim S. Virani
    Sankar D. Navaneethan
    Current Atherosclerosis Reports, 2019, 21
  • [39] Chemerin: A biomarker for cardiovascular disease in diabetic chronic kidney disease patients
    Salama, Farag E.
    Anass, Qasem A.
    Abdelrahman, Abdelnaem A.
    Saeed, Elsayed B.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2016, 27 (05) : 977 - 984
  • [40] Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease
    Ali, Sehrish
    Dave, Natasha
    Virani, Salim S.
    Navaneethan, Sankar D.
    CURRENT ATHEROSCLEROSIS REPORTS, 2019, 21 (09)